Adherence to chronic disease medications among New York City Medicaid participants

Journal of Urban Health

Volumn 90, Issue 2, 2013, Pages 323-328

  Kyanko, Kelly A ^a   Franklin, Robert H ^b   Angell, Sonia Y ^c,d  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

^c NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Cardiovascular prevention; Health disparities; Medication adherence; Public health

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; ETHNOLOGY; FEMALE; HEALTH DISPARITY; HUMAN; INSURANCE; MALE; MEDICAID; MEDICATION COMPLIANCE; MIDDLE AGED; RETROSPECTIVE STUDY; STATISTICAL MODEL; STATISTICS; UNITED STATES;

ADULT; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; FEMALE; HEALTH STATUS DISPARITIES; HUMANS; INSURANCE CLAIM REVIEW; LOGISTIC MODELS; MALE; MEDICAID; MEDICATION ADHERENCE; MIDDLE AGED; NEW YORK CITY; RETROSPECTIVE STUDIES; UNITED STATES; YOUNG ADULT;

EID: 84876288185     PISSN: 10993460     EISSN: 14682869     Source Type: Journal    
DOI: 10.1007/s11524-012-9724-4     Document Type: Article

References (18)

1. Ho PM, Bryson CL, Rumsfeld JS. Medication adherence: its importance in cardiovascular outcomes. [Review] [79 refs]. Circulation. 2009; 119(23): 3028-35.
2. Batal HA, Krantz MJ, Dale RA, Mehler PS, Steiner JF. Impact of prescription size on statin adherence and cholesterol levels. BMC Health Svc Res. 2007; 7: 175.
3. Steiner JF, Robbins LJ, Roth SC, Hammond WS. The effect of prescription size on acquisition of maintenance medications. J Gen Intern Med. 1993; 8(6): 306-10.
4. Choudhry NK, Fischer MA, Avorn J, et al. The implications of therapeutic complexity on adherence to cardiovascular medications. Arch Intern Med. 2011; 171(9): 814-22.
5. Cutler DM, Everett W. Thinking outside the pillbox - medication adherence as a priority for health care reform. New Engl J Med. 2010; 362(17): 1553-5.
6. Bluml BM, McKenney JM, Cziraky MJ. Pharmaceutical care services and results in project ImPACT: hyperlipidemia. J Am Pharm Assoc. 2000; 40(2): 157-65.
7. Center for Medicare and Medicaid Services. 2011 Medicare Part D Medication Therapy (MTM) Programs. Available at: http://www.cms.gov/ PrescriptionDrugCovContra/Downloads/MTMFactSheet2011063011Final.pdf. Accessed 1 May 2012
8. Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol. 1997; 50(1): 105-16.
9. Steiner JF, Koepsell TD, Fihn SD, Inui TS. A general method of compliance assessment using centralized pharmacy records. Description and validation. Med Care. 1988; 26(8): 814-23.
10. Schectman JM, Bovbjerg VE, Voss JD. Predictors of medication-refill adherence in an indigent rural population. Med Care. 2002; 40(12): 1294-300.
11. Halpern MT, Khan ZM, Schmier JK, et al. Recommendations for evaluating compliance and persistence with hypertension therapy using retrospective data. Hypertension. 2006; 47(6): 1039-48.
12. Chapman RH, Benner JS, Petrilla AA, et al. Predictors of adherence with antihypertensive and lipid-lowering therapy. Arch Intern Med. 2005; 165(10): 1147-52.
13. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005; 353(5): 487-97.
14. Bailey JE, Wan JY, Tang J, Ghani MA, Cushman WC. Antihypertensive medication adherence, ambulatory visits, and risk of stroke and death. J Gen Intern Med. 2010; 25(6): 495-503.
15. Traylor AH, Schmittdiel JA, Uratsu CS, Mangione CM, Subramanian U. Adherence to cardiovascular disease medications: does patient-provider race/ethnicity and language concordance matter? J Gen Intern Med. 2010; 25(11): 1172-7.
16. Chan DC, Shrank WH, Cutler D, et al. Patient, physician, and payment predictors of statin adherence. Med Care. 2010; 48(3) 196-202.
17. Shaya FT, Du D, Gbarayor CM, Frech-Tamas F, Lau H, Weir MR. Predictors of compliance with antihypertensive therapy in a high-risk medicaid population. J Natl Med Assoc. 2009; 101(1): 34-9.
18. Shenolikar RA, Balkrishnan R, Camacho FT, Whitmire JT, Anderson RT. Race and medication adherence in Medicaid enrollees with type-2 diabetes. J Natl Med Assoc. 2006; 98(7): 1071-7.